primary liver cancer
Showing 1 - 25 of >10,000
Primary Liver Cancer Early Detection
Recruiting
- Liver Cancer
- Liver-cancer early detection test
-
Changchun, Jilin, China
- +1 more
Aug 10, 2023
Liver, Cancer of, Primary Resectable Trial in Guangzhou (Oxaliplatin, Doxorubicin, Lobaplatin)
Recruiting
- Liver, Cancer of, Primary Resectable
- Oxaliplatin
- +5 more
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Jan 18, 2023
Hepatocellular Carcinoma Resectable Trial in Guangzhou (Oxaliplatin, Doxorubicin, Lobaplatin)
Recruiting
- Hepatocellular Carcinoma Resectable
- Oxaliplatin
- +5 more
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Mar 1, 2023
Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT
Active, not recruiting
- Advanced Adult Primary Liver Cancer
- +3 more
- positron emission tomography
- computed tomography
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Nov 9, 2022
Primary Liver Cancer Trial in Shanghai (Embosphere and chemo drug, Polyvinyl alcohol embolization microspheres (Huihe Medical)
Enrolling by invitation
- Primary Liver Cancer
- Embosphere and chemotherapy drug
- Polyvinyl alcohol embolization microspheres (Huihe Medical) and chemotherapy drug
-
Shanghai, Shanghai, ChinaShanghai Huihe Healthcare Tecnology Co.,Ltd.
Mar 5, 2023
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Metastatic Extrahepatic Bile Duct Cancer Trial in
Active, not recruiting
- Adult Primary Hepatocellular Carcinoma
- +6 more
- PET scan
- +2 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jul 21, 2022
Liver Transplant Disorder, Hepatic Cancer Trial (assisted liver transplantation combined with two-stage hepatectomy)
Not yet recruiting
- Liver Transplant Disorder
- Hepatic Cancer
- assisted liver transplantation combined with two-stage hepatectomy
- (no location specified)
Mar 6, 2023
Hepatocellular Carcinoma, Portal Vein Thrombosis Trial in Seoul (PBT and atezolizumab/bevacizumab)
Recruiting
- Hepatocellular Carcinoma
- Portal Vein Thrombosis
- PBT and atezolizumab/bevacizumab
-
Seoul, Korea, Republic ofSamsung Medical Center
Nov 15, 2022
l Science Network of Precision-based Immunotherapy for Primary
Recruiting
- Hepatocellular Carcinoma
- +2 more
-
La Jolla, California
- +6 more
Jan 24, 2023
Advanced Primary Liver Cancer Trial (IBR900 combined with Lenvatinib, IBR900 combined with Bevacizumab)
Not yet recruiting
- Advanced Primary Liver Cancer
- IBR900 combined with Lenvatinib
- IBR900 combined with Bevacizumab
- (no location specified)
Jun 6, 2022
Primary Liver Cancer, Non-Resectable Hepatocellular Carcinoma Trial (MRI-guided radioembolization)
Not yet recruiting
- Primary Liver Cancer
- Non-Resectable Hepatocellular Carcinoma
- MRI-guided radioembolization
- (no location specified)
Nov 1, 2022
Hepatocellular Carcinoma, Cholangiocarcinoma, Metastatic Colon Cancer Trial in Milan (Embolization)
Recruiting
- Hepatocellular Carcinoma
- +6 more
- Embolization
-
Milan, ItalyIRCCS Ospedale San Raffaele
Feb 3, 2023
Primary Liver Cancer, Secondary Liver Cancer Trial (CLINIPORATOR)
Not yet recruiting
- Primary Liver Cancer
- Secondary Liver Cancer
- CLINIPORATOR
- (no location specified)
Jul 20, 2022
Primary Liver Cancer, Secondary Liver Cancer, Liver Metastases Trial in Besançon (Interval training, Standard Oncologic care)
Completed
- Primary Liver Cancer
- +2 more
- Interval training
- Standard Oncologic care
-
Besançon, FranceChirurgie digestive, viscérale et cancérologique
Jul 18, 2022
Primary Liver Cancer, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial in China (Observation)
Recruiting
- Primary Liver Cancer
- +3 more
- Observation
-
Beijing, Beijing, China
- +4 more
Jun 14, 2022
Liver Cancer, Hepatoma Trial (Yttrium 90 (TheraSphere))
Completed
- Liver Cancer
- Hepatoma
- Yttrium 90 (TheraSphere)
- (no location specified)
Sep 28, 2022
Primary Liver Cancer, Metastatic Liver Cancer, Benign Liver Tumors Trial
Not yet recruiting
- Primary Liver Cancer
- +3 more
- (no location specified)
Aug 1, 2023
Liver Cancer Trial in Guangzhou (Indocyanine green for injection)
Recruiting
- Liver Cancer
- Indocyanine green for injection
-
Guangzhou, Guangdong, ChinaZhujiang Hospital of Southern Medical University
Jan 21, 2022
Adult Primary Hepatocellular Carcinoma, Localized Resectable Adult Primary Liver Cancer, Localized Unresectable Adult Primary
Suspended
- Adult Primary Hepatocellular Carcinoma
- +3 more
- sorafenib tosylate
- +2 more
-
Birmingham, Alabama
- +20 more
Aug 29, 2022
Primary Liver Cancers Trial in Guangzhou (3 d visualization technology)
Recruiting
- Primary Liver Cancers
- 3 d visualization technology
-
Guangzhou, Guangdong, ChinaMI-3DVS
Feb 8, 2022
Advanced Primary Liver Cancer, Advanced Biliary Tract Carcinoma Trial in Zhengzhou, Nanjing (SHR-1210, Apatinib, FOLFOX4)
Active, not recruiting
- Advanced Primary Liver Cancer
- Advanced Biliary Tract Carcinoma
- SHR-1210
- +3 more
-
Zhengzhou, Henan, China
- +1 more
Apr 26, 2022
Colorectal Tumors Trial in Hangzhou (Resin microspheres containing yttrium-90 (Y-90))
Not yet recruiting
- Colorectal Neoplasms
- Resin microspheres containing yttrium-90 (Y-90)
-
Hangzhou, Zhejiang, ChinaSir Run Run Shaw Hospital (SRRSH), affiliated with the Zhejiang
Oct 11, 2023
Single-cell RNA Sequencing Resolves Regulatory Role of HBV on
Recruiting
- HBV
- Primary Liver Cancer
- HBV DNA Sequencing
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Dec 22, 2022
Liver Metastases, Liver Cancer, Liver Tumors Trial in Warsaw (PVE, LVD, ALPPS)
Not yet recruiting
- Liver Metastases
- +3 more
- PVE
- +2 more
-
Warsaw, Mazowieckie, PolandSecond Department of Clinical Radiology
Sep 17, 2023
Adult Primary Liver Cancer, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer Trial in
Recruiting
- Adult Primary Liver Cancer
- +2 more
- TSR-022 and TSR-042
-
Honolulu, HawaiiUniversity of Hawaii
Sep 22, 2021